Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

RB1 activates CYLD. 2 / 2

| 2

➶

reach

"Vinblastine acts by RB, APOP and RTK pathways targeting CDKN2A, CYLD and NF1 genes which have role in melanoma, pilotrichomas and neurofibroma respectively."

29859466

➶

reach

"Lutein and hydroxyl radicals act by APOP, RTK and RB pathways targeting CYLD, NF, RB genes which are responsible for pilotrichomas, neurofibroma and intraocular melanoma respectively."

29859466

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...